Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. [electronic resource]
- Circulation Sep 2016
- e156-78 p. digital
Publication Type: Journal Article; Review; Systematic Review
1524-4539
10.1161/CIR.0000000000000405 doi
Advisory Committees--standards
American Heart Association
Aspirin--administration & dosage
Cardiology--methods
Coronary Artery Disease--diagnosis
Drug Administration Schedule
Drug Therapy, Combination
Drug-Eluting Stents--adverse effects
Hemorrhage--chemically induced
Humans
Platelet Aggregation Inhibitors--administration & dosage
Practice Guidelines as Topic--standards
Purinergic P2Y Receptor Antagonists--administration & dosage
Randomized Controlled Trials as Topic--methods
Research Report--standards
Thrombosis--etiology
Time Factors
United States--epidemiology
Publication Type: Journal Article; Review; Systematic Review
1524-4539
10.1161/CIR.0000000000000405 doi
Advisory Committees--standards
American Heart Association
Aspirin--administration & dosage
Cardiology--methods
Coronary Artery Disease--diagnosis
Drug Administration Schedule
Drug Therapy, Combination
Drug-Eluting Stents--adverse effects
Hemorrhage--chemically induced
Humans
Platelet Aggregation Inhibitors--administration & dosage
Practice Guidelines as Topic--standards
Purinergic P2Y Receptor Antagonists--administration & dosage
Randomized Controlled Trials as Topic--methods
Research Report--standards
Thrombosis--etiology
Time Factors
United States--epidemiology